Co-careldopa (Carbidopa/levodopa) vs Tafamidis meglumine (old)
National NHS prescribing compared (Prescription Cost Analysis)
Co-careldopa (Carbidopa/levodopa) was dispensed 130,130.0× as often as Tafamidis meglumine (old) in April 2026 — 130,130 items versus 1 in England.
130,130items
Co-careldopa (Carbidopa/levodopa) · April 2026
NHSBSA Prescription Cost Analysis
1items
Tafamidis meglumine (old) · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-careldopa (Carbidopa/levodopa) versus Tafamidis meglumine (old): national items dispensed by month
▬ Co-careldopa (Carbidopa/levodopa) · ╌ Tafamidis meglumine (old)
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Co-careldopa (Carbidopa/levodopa) | Tafamidis meglumine (old) |
|---|---|---|
| Items, April 2026 | 130,130 | 1 |
| Items, last 12 months | 1,545,734 | 1 |
| Net ingredient cost, April 2026 | £1,181,918 | £712 |
See the full profile for Co-careldopa (Carbidopa/levodopa) or Tafamidis meglumine (old).